Advertisement

Imaging and PET-CT of head and neck cancers (in French)

  • C. Maunoury
    Affiliations
    (P.H.: Départment de Phyiology et Radio-Isotopes, Hôpital Européen Georges Pompidou, 20 rue Leblanc, F-75908 Paris Cedex 15, France). J Radiol 2008;89:403-412.
    Search for articles by this author
  • P. Halimi
    Affiliations
    (P.H.: Départment de Phyiology et Radio-Isotopes, Hôpital Européen Georges Pompidou, 20 rue Leblanc, F-75908 Paris Cedex 15, France). J Radiol 2008;89:403-412.
    Search for articles by this author
      PET/CT is essential before extensive and mutilating surgery to exclude metastases; is mandatory to assess the efficiency of concurrent cytoreductive chemoradiotherapy for organ preservation treatment; is required for surgical follow-up to detect local recurrences, metastases, or metachronous lesions; is useful to identify the primary lesion in patients with metastases from unknown primary site; and is useful to assess metabolic tumoral volumes, especially nodes, before radiotherapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect